{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:16:30Z","timestamp":1789614990373,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T00:00:00Z","timestamp":1436227200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12866-015-0473-x","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T05:06:36Z","timestamp":1436159196000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms"],"prefix":"10.1186","volume":"15","author":[{"given":"Susana","family":"S\u00e1nchez-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Ferrer-Espada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsey","family":"Pitts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Lohner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Mart\u00ednez de Tejada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,7]]},"reference":[{"key":"473_CR1","doi-asserted-by":"crossref","unstructured":"Lodise TP, Patel N, Kwa A, Graves J, Furuno JP, Graffunder E, et al. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother. 2007;51:3510\u20135.","DOI":"10.1128\/AAC.00338-07"},{"key":"473_CR2","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1128\/AAC.00207-10","volume":"54","author":"VH Tam","year":"2010","unstructured":"Tam VH, Rogers CA, Chang KT, Weston JS, Caeiro JP, Garey KW. Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes. Antimicrob Agents Chemother. 2010;54:3717\u201322.","journal-title":"Antimicrob Agents Chemother"},{"key":"473_CR3","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1128\/AAC.45.4.999-1007.2001","volume":"45","author":"K Lewis","year":"2001","unstructured":"Lewis K. Riddle of biofilm resistance. Antimicrob Agents Chemother. 2001;45:999\u20131007.","journal-title":"Antimicrob Agents Chemother"},{"key":"473_CR4","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1128\/MMBR.64.4.847-867.2000","volume":"64","author":"ME Davey","year":"2000","unstructured":"Davey ME, O\u2019Toole GA. Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev. 2000;64:847\u201367.","journal-title":"Microbiol Mol Biol Rev"},{"key":"473_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1128\/CMR.15.2.167-193.2002","volume":"15","author":"RM Donlan","year":"2002","unstructured":"Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15:167\u201393.","journal-title":"Clin Microbiol Rev"},{"key":"473_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0140-6736(01)05321-1","volume":"358","author":"PS Stewart","year":"2001","unstructured":"Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001;358:135\u20138.","journal-title":"Lancet"},{"key":"473_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1128\/CMR.00056-05","volume":"19","author":"H Jenssen","year":"2006","unstructured":"Jenssen H, Hamill P, Hancock REW. Peptide antimicrobial agents. Clin Microbiol Rev. 2006;19:491\u2013511.","journal-title":"Clin Microbiol Rev"},{"key":"473_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4149\/gpb_2009_02_105","volume":"28","author":"K Lohner","year":"2009","unstructured":"Lohner K. New strategies for novel antibiotics: peptides targeting bacterial cell membranes. Gen Physiol Biophys. 2009;28:105\u201316.","journal-title":"Gen Physiol Biophys"},{"key":"473_CR9","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1128\/AAC.46.3.689-694.2002","volume":"46","author":"S Navon-Venezia","year":"2002","unstructured":"Navon-Venezia S, Feder R, Gaidukov L, Carmeli Y, Mor A. Antibacterial properties of dermaseptin S4 derivatives with in vivo activity. Antimicrob Agents Chemother. 2002;46:689\u201394.","journal-title":"Antimicrob Agents Chemother"},{"key":"473_CR10","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1128\/AAC.49.7.2921-2927.2005","volume":"49","author":"L Zhang","year":"2005","unstructured":"Zhang L, Parente J, Harris SM, Woods DE, Hancock REW, Falla TJ. Antimicrobial peptide therapeutics for cystic fibrosis. Antimicrob Agents Chemother. 2005;49:2921\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"473_CR11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2174\/092986711794088399","volume":"18","author":"G Batoni","year":"2011","unstructured":"Batoni G, Maisetta G, Brancatisano FL, Esin S, Campa M. Use of antimicrobial peptides against microbial biofilms: advantages and limits. Curr Med Chem. 2011;18:256\u201379.","journal-title":"Curr Med Chem"},{"key":"473_CR12","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1007\/s00018-005-5373-z","volume":"62","author":"JL Gifford","year":"2005","unstructured":"Gifford JL, Hunter HN, Vogel HJ. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell Mol Life Sci. 2005;62:2588\u201398.","journal-title":"Cell Mol Life Sci"},{"key":"473_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1023\/B:BIOM.0000027691.86757.e2","volume":"17","author":"N Orsi","year":"2004","unstructured":"Orsi N. The antimicrobial activity of lactoferrin: current status and perspectives. Biometals. 2004;17:189\u201396.","journal-title":"Biometals"},{"key":"473_CR14","doi-asserted-by":"crossref","unstructured":"Sanchez-Gomez S, Lamata M, Leiva J, Blondelle SE, Jerala R, Andra J, et al. Comparative analysis of selected methods for the assessment of antimicrobial and membrane-permeabilizing activity: a case study for lactoferricin derived peptides. BMC Microbiol. 2008;8:196.","DOI":"10.1186\/1471-2180-8-196"},{"key":"473_CR15","doi-asserted-by":"crossref","unstructured":"Sanchez-Gomez S, Japelj B, Jerala R, Moriyon I, Fern\u00e1ndez Alonso M, Leiva J, et al. Structural features governing the activity of lactoferricin-derived peptides that act in synergy with antibiotics against Pseudomonas aeruginosa in vitro and in vivo. Antimicrob Agents Chemother. 2011;55:218\u201328.","DOI":"10.1128\/AAC.00904-10"},{"key":"473_CR16","doi-asserted-by":"crossref","unstructured":"Zweytick D, Deutsch G, Andra J, Blondelle SE, Vollmer E, Jerala R, et al. Studies on lactoferricin-derived Escherichia coli membrane-active peptides reveal differences in the mechanism of N-acylated versus nonacylated peptides. J Biol Chem. 2011;286:21266\u201376.","DOI":"10.1074\/jbc.M110.195412"},{"key":"473_CR17","doi-asserted-by":"crossref","unstructured":"Martinez de Tejada G, Sanchez-Gomez S, Razquin-Olazaran I, Kowalski I, Kaconis Y, Heinbockel L, et al. Bacterial cell wall compounds as promising targets of antimicrobial agents I. Antimicrobial peptides and lipopolyamines. Curr Drug Targets. 2012;13:1121\u201330.","DOI":"10.2174\/138945012802002410"},{"key":"473_CR18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.bbamem.2008.10.015","volume":"1788","author":"M Zorko","year":"2009","unstructured":"Zorko M, Japelj B, Hafner-Bratkovic I, Jerala R. Expression, purification and structural studies of a short antimicrobial peptide. Biochim Biophys Acta. 2009;1788:314\u201323.","journal-title":"Biochim Biophys Acta"},{"key":"473_CR19","doi-asserted-by":"crossref","unstructured":"Andra J, Lohner K, Blondelle SE, Jerala R, Moriyon I, Koch MHJ, et al. Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide. Biochem J. 2005;385:135\u201343.","DOI":"10.1042\/BJ20041270"},{"key":"473_CR20","doi-asserted-by":"crossref","unstructured":"Zweytick D, Pabst G, Abuja PM, Jilek A, Blondelle SE, Andra J, et al. Influence of N-acylation of a peptide derived from human lactoferricin on membrane selectivity. Biochim Biophys Acta. 2006;1758:1426\u201335.","DOI":"10.1016\/j.bbamem.2006.02.032"},{"key":"473_CR21","doi-asserted-by":"crossref","unstructured":"Japelj B, Zorko M, Majerle A, Pristovsek P, Sanchez-Gomez S, Martinez de Tejada G, et al. The acyl group as the central element of the structural organization of antimicrobial lipopeptide. J Am Chem Soc. 2007;129:1022\u20133.","DOI":"10.1021\/ja067419v"},{"key":"473_CR22","doi-asserted-by":"crossref","unstructured":"Brandenburg K, Howe J, Sanchez-Gomez S, Garidel P, Roessle M, Andra J, et al. Effective antimicrobial and anti-endotoxin activity of cationic peptides based on lactoferricin: a biophysical and microbiological study. Antiinfect Agents Med Chem. 2010;9:9\u201322.","DOI":"10.2174\/187152110790886736"},{"key":"473_CR23","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1128\/AAC.49.6.2412-2420.2005","volume":"49","author":"IS Radzishevsky","year":"2005","unstructured":"Radzishevsky IS, Rotem S, Zaknoon F, Gaidukov L, Dagan A, Mor A. Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides. Antimicrob Agents Chemother. 2005;49:2412\u201320.","journal-title":"Antimicrob Agents Chemother"},{"key":"473_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1747-0285.2011.01086.x","volume":"77","author":"Z Jiang","year":"2011","unstructured":"Jiang Z, Vasil AI, Gera L, Vasil ML, Hodges RS. Rational design of \u03b1-helical antimicrobial peptides to target gram-negative pathogens, acinetobacter baumannii and pseudomonas aeruginosa: utilization of charge, \u201cSpecificity Determinants\u201d, total hydrophobicity, hydrophobe type and location as design parameters to improve the therapeutic ratio. Chem Biol Drug Des. 2011;77:225\u201340.","journal-title":"Chem Biol Drug Des"},{"key":"473_CR25","doi-asserted-by":"publisher","first-page":"7609","DOI":"10.1021\/ja8093247","volume":"131","author":"R Rathinakumar","year":"2009","unstructured":"Rathinakumar R, Walkenhorst WF, Wimley WC. Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. J Am Chem Soc. 2009;131:7609\u201317.","journal-title":"J Am Chem Soc"},{"key":"473_CR26","doi-asserted-by":"publisher","first-page":"9849","DOI":"10.1021\/ja8017863","volume":"130","author":"R Rathinakumar","year":"2008","unstructured":"Rathinakumar R, Wimley WC. Biomolecular engineering by combinatorial design and high-throughput screening: small, soluble peptides that permeabilize membranes. J Am Chem Soc. 2008;130:9849\u201358.","journal-title":"J Am Chem Soc"},{"key":"473_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1124\/pr.55.1.2","volume":"55","author":"MR Yeaman","year":"2003","unstructured":"Yeaman MR. Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev. 2003;55:27\u201355.","journal-title":"Pharmacol Rev"},{"key":"473_CR28","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1128\/AAC.00925-06","volume":"51","author":"Y Chen","year":"2007","unstructured":"Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS. Role of peptide hydrophobicity in the mechanism of action of -helical antimicrobial peptides. Antimicrob Agents Chemother. 2007;51:1398\u2013406.","journal-title":"Antimicrob Agents Chemother"},{"key":"473_CR29","doi-asserted-by":"publisher","first-page":"16941","DOI":"10.1074\/jbc.M111071200","volume":"277","author":"I Kustanovich","year":"2002","unstructured":"Kustanovich I. Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives. J Biol Chem. 2002;277:16941\u201351.","journal-title":"J Biol Chem"},{"key":"473_CR30","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1016\/j.peptides.2005.05.002","volume":"26","author":"I Zelezetsky","year":"2005","unstructured":"Zelezetsky I, Pag U, Sahl H-G, Tossi A. Tuning the biological properties of amphipathic \u03b1-helical antimicrobial peptides: rational use of minimal amino acid substitutions. Peptides. 2005;26:2368\u201376.","journal-title":"Peptides"},{"key":"473_CR31","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/bip.20911","volume":"90","author":"Z Jiang","year":"2008","unstructured":"Jiang Z, Vasil AI, Hale JD, Hancock REW, Vasil ML, Hodges RS. Effects of net charge and the number of positively charged residues on the biological activity of amphipathic \u03b1-helical cationic antimicrobial peptides. Biopolymers. 2008;90:369\u201383.","journal-title":"Biopolymers"},{"key":"473_CR32","doi-asserted-by":"crossref","unstructured":"Gopal R, Kim YG, Lee JH, Lee SK, Chae JD, Son BK, et al. Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains. Antimicrob Agents Chemother. 2014;58:1622\u20139.","DOI":"10.1128\/AAC.02473-13"},{"key":"473_CR33","doi-asserted-by":"crossref","unstructured":"Zairi A, Ferrieres L, Latour-Lambert P, Beloin C, Tangy F, Ghigo J-M, et al. In vitro activities of dermaseptins K4S4 and K4K20S4 against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa planktonic growth and biofilm formation. Antimicrob Agents Chemother. 2014;58:2221\u20138.","DOI":"10.1128\/AAC.02142-13"},{"key":"473_CR34","doi-asserted-by":"crossref","unstructured":"Beckloff N, Laube D, Castro T, Furgang D, Park S, Perlin D, et al. Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens. Antimicrob Agents Chemother. 2007;51:4125\u201332.","DOI":"10.1128\/AAC.00208-07"},{"key":"473_CR35","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ijantimicag.2007.11.012","volume":"31","author":"S Roveta","year":"2008","unstructured":"Roveta S, Marchese A, Schito GC. Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp. Int J Antimicrob Agents. 2008;31:321\u20138.","journal-title":"Int J Antimicrob Agents"},{"key":"473_CR36","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/jac\/dkl120","volume":"57","author":"GX Wei","year":"2006","unstructured":"Wei GX. Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J Antimicrob Chemother. 2006;57:1100\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"473_CR37","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/417552a","volume":"417","author":"PK Singh","year":"2002","unstructured":"Singh PK, Parsek MR, Greenberg EP, Welsh MJ. A component of innate immunity prevents bacterial biofilm development. Nature. 2002;417:552\u20135.","journal-title":"Nature"},{"key":"473_CR38","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1023\/B:BIOM.0000027703.77456.27","volume":"17","author":"PK Singh","year":"2004","unstructured":"Singh PK. Iron sequestration by human lactoferrin stimulates P. aeruginosa surface motility and blocks biofilm formation. Biometals. 2004;17:267\u201370.","journal-title":"Biometals"},{"key":"473_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10156-011-0287-1","volume":"18","author":"H Kamiya","year":"2012","unstructured":"Kamiya H, Ehara T, Matsumoto T. Inhibitory effects of lactoferrin on biofilm formation in clinical isolates of Pseudomonas aeruginosa. J Infect Chemother. 2012;18:47\u201352.","journal-title":"J Infect Chemother"},{"key":"473_CR40","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1399-302X.2009.00537.x","volume":"24","author":"SY Arslan","year":"2009","unstructured":"Arslan SY, Leung KP, Wu CD. The effect of lactoferrin on oral bacterial attachment. Oral Microbiol Immunol. 2009;24:411\u20136.","journal-title":"Oral Microbiol Immunol"},{"key":"473_CR41","doi-asserted-by":"crossref","unstructured":"Berlutti F, Ajello M, Bosso P, Morea C, Petrucca A, Antonini G, et al. Both lactoferrin and iron influence aggregation and biofilm formation in Streptococcus mutans. Biometals. 2004;17:271\u20138.","DOI":"10.1023\/B:BIOM.0000027704.53859.d3"},{"key":"473_CR42","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1093\/jac\/dkm222","volume":"60","author":"EM Caraher","year":"2007","unstructured":"Caraher EM, Gumulapurapu K, Taggart CC, Murphy P, McClean S, Callaghan M. The effect of recombinant human lactoferrin on growth and the antibiotic susceptibility of the cystic fibrosis pathogen Burkholderia cepacia complex when cultured planktonically or as biofilms. J Antimicrob Chemother. 2007;60:546\u201354.","journal-title":"J Antimicrob Chemother"},{"key":"473_CR43","doi-asserted-by":"crossref","unstructured":"O\u2019May CY, Sanderson K, Roddam LF, Kirov SM, Reid DW. Iron-binding 3compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions. J Med Microbiol. 2009;58:765\u201373.","DOI":"10.1099\/jmm.0.004416-0"},{"key":"473_CR44","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1128\/AAC.01688-08","volume":"53","author":"H Wakabayashi","year":"2009","unstructured":"Wakabayashi H, Yamauchi K, Kobayashi T, Yaeshima T, Iwatsuki K, Yoshie H. Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia. Antimicrob Agents Chemother. 2009;53:3308\u201316.","journal-title":"Antimicrob Agents Chemother"},{"key":"473_CR45","doi-asserted-by":"crossref","unstructured":"Xu G, Xiong W, Hu Q, Zuo P, Shao B, Lan F, et al. Lactoferrin-derived peptides and Lactoferricin chimera inhibit virulence factor production and biofilm formation in Pseudomonas aeruginosa. J Appl Microbiol. 2010;109:1311\u20138.","DOI":"10.1111\/j.1365-2672.2010.04751.x"},{"key":"473_CR46","doi-asserted-by":"publisher","first-page":"e1004152","DOI":"10.1371\/journal.ppat.1004152","volume":"10","author":"C la Fuente-N\u00fa\u00f1ez de","year":"2014","unstructured":"la Fuente-N\u00fa\u00f1ez de C, Reffuveille F, Haney EF, Straus SK, Hancock REW. Broad-spectrum anti-biofilm peptide that targets a cellular stress response. PLoS Pathog. 2014;10:e1004152.","journal-title":"PLoS Pathog"},{"key":"473_CR47","doi-asserted-by":"crossref","unstructured":"la Fuente-N\u00fa\u00f1ez de C, Korolik V, Bains M, Nguyen U, Breidenstein EBM, Horsman S, et al. Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide. Antimicrob Agents Chemother. 2012;56:2696\u2013704.","DOI":"10.1128\/AAC.00064-12"},{"key":"473_CR48","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1099\/jmm.0.050807-0","volume":"62","author":"C Nagant","year":"2013","unstructured":"Nagant C, Seil M, Nachtergael A, Dulanto S, Dehaye JP. Contribution of the production of quormones to some phenotypic characteristics of Pseudomonas aeruginosa clinical strains. J Med Microbiol. 2013;62:951\u20138.","journal-title":"J Med Microbiol"},{"key":"473_CR49","doi-asserted-by":"crossref","unstructured":"Hill D, Rose B, Pajkos A, Robinson M, Bye P, Bell S, et al. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. J Clin Microbiol. 2005;43:5085\u201390.","DOI":"10.1128\/JCM.43.10.5085-5090.2005"},{"key":"473_CR50","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2958.2008.06152.x","volume":"68","author":"SJ Pamp","year":"2008","unstructured":"Pamp SJ, Gjermansen M, Johansen HK, Tolker-Nielsen T. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol Microbiol. 2008;68:223\u201340.","journal-title":"Mol Microbiol"},{"key":"473_CR51","doi-asserted-by":"crossref","unstructured":"Herrmann G, Yang L, Wu H, Song Z, Wang H, H\u00f8iby N, et al. Colistin-Tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa. J Infect Dis. 2010;202:1585\u201392.","DOI":"10.1086\/656788"},{"key":"473_CR52","doi-asserted-by":"crossref","unstructured":"Eckert R, Brady KM, Greenberg EP, Qi F, Yarbrough DK, He J, et al. Enhancement of antimicrobial activity against Pseudomonas aeruginosa by coadministration of G10KHc and tobramycin. Antimicrob Agents Chemother. 2006;50:3833\u20138.","DOI":"10.1128\/AAC.00509-06"},{"key":"473_CR53","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1128\/AEM.72.3.2064-2069.2006","volume":"72","author":"E Banin","year":"2006","unstructured":"Banin E, Brady KM, Greenberg EP. Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl Environ Microbiol. 2006;72:2064\u20139.","journal-title":"Appl Environ Microbiol"},{"key":"473_CR54","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1128\/JB.183.3.1047-1057.2001","volume":"183","author":"DE Nivens","year":"2001","unstructured":"Nivens DE, Ohman DE, Williams J, Franklin MJ. Role of alginate and its O acetylation in formation of Pseudomonas aeruginosa microcolonies and biofilms. J Bacteriol. 2001;183:1047\u201357.","journal-title":"J Bacteriol"},{"key":"473_CR55","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0167-7012(03)00034-4","volume":"54","author":"B Pitts","year":"2003","unstructured":"Pitts B, Hamilton MA, Zelver N, Stewart PS. A microtiter-plate screening method for biofilm disinfection and removal. J Microbiol Methods. 2003;54:269\u201376.","journal-title":"J Microbiol Methods"},{"key":"473_CR56","doi-asserted-by":"crossref","unstructured":"Andra J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, et al. Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens. J Biol Chem. 2007;282:14719\u201328.","DOI":"10.1074\/jbc.M608920200"},{"key":"473_CR57","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1046\/j.1365-2958.1998.01062.x","volume":"30","author":"GA O\u2019Toole","year":"1998","unstructured":"O\u2019Toole GA, Kolter R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol. 1998;30:295\u2013304.","journal-title":"Mol Microbiol"},{"key":"473_CR58","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1099\/mic.0.27709-0","volume":"151","author":"DM Goeres","year":"2005","unstructured":"Goeres DM, Loetterle LR, Hamilton MA, Murga R, Kirby DW, Donlan RM. Statistical assessment of a laboratory method for growing biofilms. Microbiology (Reading, Engl). 2005;151:757\u201362.","journal-title":"Microbiology (Reading, Engl)"},{"key":"473_CR59","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.1021\/bi9600153","volume":"35","author":"WC Wimley","year":"1996","unstructured":"Wimley WC, Creamer TP, White SH. Solvation energies of amino acid side chains and backbone in a family of host-guest pentapeptides. Biochemistry. 1996;35:5109\u201324.","journal-title":"Biochemistry"},{"key":"473_CR60","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1002\/pro.256","volume":"18","author":"C Snider","year":"2009","unstructured":"Snider C, Jayasinghe S, Hristova K, White SH. MPEx: a tool for exploring membrane proteins. Protein Sci. 2009;18:2624\u20138.","journal-title":"Protein Sci"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12866-015-0473-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-015-0473-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-015-0473-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-015-0473-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T20:57:11Z","timestamp":1566939431000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-015-0473-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,7]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["473"],"URL":"https:\/\/doi.org\/10.1186\/s12866-015-0473-x","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,7]]},"assertion":[{"value":"18 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"137"}}